The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Liver Cirrhosis, Experimental

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Liver Cirrhosis, Experimental

  • When exogenous ANP is administered intravenously to dogs or rats with experimental liver cirrhosis and ascites, an heterogeneous natriuretic response is obtained with about half of the population not responding [1].
 

High impact information on Liver Cirrhosis, Experimental

 

Biological context of Liver Cirrhosis, Experimental

 

Associations of Liver Cirrhosis, Experimental with chemical compounds

 

Gene context of Liver Cirrhosis, Experimental

References

  1. Atrial natriuretic peptide: renal effects in cirrhosis of the liver. Levy, M. Semin. Nephrol. (1997) [Pubmed]
  2. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Rudolph, K.L., Chang, S., Millard, M., Schreiber-Agus, N., DePinho, R.A. Science (2000) [Pubmed]
  3. Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats. Cruz, A., Padillo, F.J., Torres, E., Navarrete, C.M., Muñoz-Castañeda, J.R., Caballero, F.J., Briceño, J., Marchal, T., Túnez, I., Montilla, P., Pera, C., Muntané, J. J. Pineal Res. (2005) [Pubmed]
  4. Enhanced synthesis and reduced metabolism of endothelin-1 (ET-1) by hepatocytes--an important mechanism of increased endogenous levels of ET-1 in liver cirrhosis. Kuddus, R.H., Nalesnik, M.A., Subbotin, V.M., Rao, A.S., Gandhi, C.R. J. Hepatol. (2000) [Pubmed]
  5. Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats. Tsuboi, Y., Ishikawa, S., Fujisawa, G., Okada, K., Saito, T. Kidney Int. (1994) [Pubmed]
  6. Role of the heme oxygenases in abnormalities of the mesenteric circulation in cirrhotic rats. Sacerdoti, D., Abraham, N.G., Oyekan, A.O., Yang, L., Gatta, A., McGiff, J.C. J. Pharmacol. Exp. Ther. (2004) [Pubmed]
  7. Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis. Lakatos, P.L., Firneisz, G., Borcsiczky, D., Zalatnai, A., Selmeci, L., Szalay, F. Eur. J. Clin. Invest. (2000) [Pubmed]
  8. Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration. Hori, N., Okanoue, T., Sawa, Y., Mori, T., Kashima, K. Dig. Dis. Sci. (1993) [Pubmed]
  9. Role of prostaglandins and thromboxane in the control of renal hemodynamics in experimental liver cirrhosis. Leehey, D.J., Uckerman, M.T., Rahman, M.A. J. Lab. Clin. Med. (1989) [Pubmed]
  10. The influence of an experimental liver cirrhosis upon the metabolism of diazepam and imipramine hydrochloride in the rat. Trennery, P.N., Waring, R.H. Xenobiotica (1985) [Pubmed]
  11. Serum amino acid changes in rats with thioacetamide-induced liver cirrhosis. Fontana, L., Moreira, E., Torres, M.I., Fernández, M.I., Ríos, A., Sánchez de Medina, F., Gil, A. Toxicology (1996) [Pubmed]
  12. Methylthioadenosine phosphorylase gene expression is impaired in human liver cirrhosis and hepatocarcinoma. Berasain, C., Hevia, H., Fernández-Irigoyen, J., Larrea, E., Caballería, J., Mato, J.M., Prieto, J., Corrales, F.J., García-Trevijano, E.R., Avila, M.A. Biochim. Biophys. Acta (2004) [Pubmed]
  13. Renal endothelin system in rats with liver cirrhosis. Hocher, B., Zart, R., Diekmann, F., Gross, P., Distler, A., Bauer, C. J. Cardiovasc. Pharmacol. (1995) [Pubmed]
  14. Expression and distribution of the prolactin receptor in normal rat liver and in experimental liver cirrhosis. Kloehn, S., Otte, C., Korsanke, M., Arendt, T., Clemens, A., Glasow, A., Bornstein, S.R., Fölsch, U.R., Mönig, H. Horm. Metab. Res. (2001) [Pubmed]
  15. Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis. García-Fernández, M., Castilla-Cortázar, I., Díaz-Sanchez, M., Navarro, I., Puche, J.E., Castilla, A., Casares, A.D., Clavijo, E., González-Barón, S. BMC gastroenterology [electronic resource]. (2005) [Pubmed]
 
WikiGenes - Universities